TARGETING THE PERIPHERAL T‐CELL LYMPHOMA (PTCL) EPIGENOME WITH ORAL 5‐AZACYTIDINE AND ROMIDEPSIN: RESULTS AND CLINICAL‐MOLECULAR CORRELATIONS FROM A PHASE 2 STUDY. (12th June 2019)

• Record Type: Journal Article
• Authors: Falchi, L.; Lue, J.K.; Montanari, F.; Marchi, E.; Amengual, J.E.; Sawas, A.; Deng, C.; Khan, K.; Kim, H.A.; Rada, A.; Malanga, M.; Francescone, M.F.; Soderquist, C.R.; Park, D.C.; Bhagat, G.; Sokol, L.; Shustov, A.R.; O'Connor, O.A.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 178
• Page End: 179
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.135_2629
• Languages: English
• ISSNs: 0278-0232